ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,732.93
      0.25%
      US Tech 100
      19,426.00
      0.54%
      Dow Jones
      42,208.22
      0.20%
      Brent Oil
      74.275
      -0.38%
      Bitcoin
      64,262.19
      -0.01%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. Cel Sci Corporation New (CVM)

      7. Cel Sci Corporation New (CVM) News

      CVM

      Cel Sci (CVM)

      Cel Sci Corporation New
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:CVM
      DateTimeSourceHeadlineSymbolCompany
      12:50PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference
      12:45PMiHub NewswireFeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.
      09/16/20247:30AMBusiness WireCEL-SCI’s Multikine® Increased 5-Year Survival Rate to 82.6% in Locally Advanced Resectable Head & Neck Cancer Patients Who Were Deemed to be in the Treatment Group for Surgery and RadiationAMEX:CVMCel Sci Corporation New
      09/10/20249:32AMBusiness WireCEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 CongressAMEX:CVMCel Sci Corporation New
      09/04/20249:00AMBusiness WireThe UK’s Medicines & Healthcare Products Regulatory Agency Grants CEL-SCI a Pediatric Waiver, Bringing Multikine® One Step Closer to Future Marketing ClearanceAMEX:CVMCel Sci Corporation New
      08/30/20244:32PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:CVMCel Sci Corporation New
      08/15/20248:00AMBusiness WireCEL-SCI Corporation Reports Third Quarter Fiscal 2024 Financial ResultsAMEX:CVMCel Sci Corporation New
      08/14/20244:27PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CVMCel Sci Corporation New
      07/29/20245:16PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
      07/29/20244:05PMBusiness WireCEL-SCI Announces Closing of $10.8 Million OfferingAMEX:CVMCel Sci Corporation New
      07/29/20247:00AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:CVMCel Sci Corporation New
      07/26/20245:27PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
      07/26/202411:52AMBusiness WireCEL-SCI Announces Pricing of $10.8 Million OfferingAMEX:CVMCel Sci Corporation New
      07/26/20248:23AMBusiness WireCEL-SCI’s Phase 3 Population Analysis for Upcoming Confirmatory Registration Study in Head & Neck Cancer Demonstrates Well Balanced Patient Population, Confidence in Clinical ResultsAMEX:CVMCel Sci Corporation New
      07/08/20249:15AMBusiness WireCEL-SCI Appoints Robert Watson as Chairperson of the BoardAMEX:CVMCel Sci Corporation New
      06/18/20248:00AMBusiness WireCEL-SCI Presents Head & Neck Cancer Data at Iddst Annual Congress in Budapest: Risk of Death Cut in Half for Patients Treated With Multikine in the Target PopulationAMEX:CVMCel Sci Corporation New
      06/06/20247:00AMBusiness WireDr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical AdvisorAMEX:CVMCel Sci Corporation New
      05/16/20249:00AMBusiness WireCEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial ResultsAMEX:CVMCel Sci Corporation New
      05/15/20244:17PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CVMCel Sci Corporation New
      05/10/20249:04AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
      05/09/20241:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
      05/09/20249:19AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
      05/08/20249:00AMBusiness WireCEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck CancerAMEX:CVMCel Sci Corporation New
      04/23/20249:00AMBusiness WireCEL-SCI Appoints Mario Gobbo to Its Board of DirectorsAMEX:CVMCel Sci Corporation New
      03/19/20249:00AMBusiness WireCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in ImmunologyAMEX:CVMCel Sci Corporation New
      03/07/202411:33AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:CVMCel Sci Corporation New
      03/07/202411:33AMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:CVMCel Sci Corporation New
      03/07/202411:31AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:CVMCel Sci Corporation New
      03/06/20248:45AMBusiness WireCEL-SCI Corporation Issues Letter to ShareholdersAMEX:CVMCel Sci Corporation New
      02/15/20248:00AMBusiness WireCEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial ResultsAMEX:CVMCel Sci Corporation New
       Showing the most relevant articles for your search:AMEX:CVM